Furthermore, a morphological analysis by a phase contrast microscopy showed that the morphological features of the cells were changed significantly, post-MHC-exposure and that they were represented by cellular shrinkage and cluster-forming cells that were detached previously from the surface; therefore, indicating the therapeutical relevance of MHC in a dose-dependent manner for the management of breast cancer cells. This evidence concerns the gene HLA-C and breast carcinoma.